Page last updated: 2024-11-02

pamidronate and Aggressive Systemic Mastocytosis

pamidronate has been researched along with Aggressive Systemic Mastocytosis in 3 studies

Aggressive Systemic Mastocytosis: A form of systemic mastocytosis in which patients have impaired organ functions due to multifocal infiltrates of pathological MAST CELLS in bone marrow, liver, spleen, gastrointestinal tract, or skeletal system. The cytomorphology shows a low to high grade.

Research Excerpts

ExcerptRelevanceReference
"Systemic mastocytosis is characterised by proliferation of mast cells and infiltration of organs."1.33Involvement of the jaw bones in systemic mastocytosis. ( Castling, B; Myers, B; Smith, AT, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Myers, B2
Castling, B1
Smith, AT1
Laroche, M1
Bret, J1
Brouchet, A1
Mazières, B1

Other Studies

3 other studies available for pamidronate and Aggressive Systemic Mastocytosis

ArticleYear
Comment on systemic mastocytosis study.
    British journal of haematology, 2003, Volume: 121, Issue:3

    Topics: Adult; Diphosphonates; Humans; Interferon-alpha; Male; Mastocytosis, Systemic; Middle Aged; Pain; Pa

2003
Involvement of the jaw bones in systemic mastocytosis.
    The British journal of oral & maxillofacial surgery, 2006, Volume: 44, Issue:2

    Topics: Adult; Bone Density Conservation Agents; Diphosphonates; Histamine H1 Antagonists; Humans; Jaw Neopl

2006
Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis.
    Clinical rheumatology, 2007, Volume: 26, Issue:2

    Topics: Adult; Aged; Anti-Inflammatory Agents; Bone Density; Bone Marrow Cells; Bone Remodeling; Diphosphona

2007